Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Popovic, Natasa (15832791100)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clinicopathological characteristics and survival in Serbian patients with renal cell carcinoma: A retrospective analysis
    (2017)
    Pavlovic, Ivan (56769363700)
    ;
    Pejic, Snezana (6602841944)
    ;
    Glumac, Sofija (33467624700)
    ;
    Todorovic, Ana (8930796800)
    ;
    Stojiljkovic, Vesna (8930796500)
    ;
    Popovic, Natasa (15832791100)
    ;
    Gavrilovic, Ljubica (23060209300)
    ;
    Pajovic, Snezana B. (6701715237)
    ;
    Radojevic-Skodric, Sanja (15726145200)
    ;
    Dzamic, Zoran (6506981365)
    ;
    Basta-Jovanovic, Gordana (6603093303)
    Purpose: Indications of kidney cancer outcome in lower-income countries are based on an incidence/mortality ratio due to lack of survival information. This study was conducted to provide outcome data in Serbian patients with renal cell carcinoma (RCC) and to identify prognostic factors that could affect their overall survival (OS). Methods: This retrospective study included 185 patients who underwent nephrectomy. We assessed certain clinicopathological data including age, gender, tumor size, grade, stage and histological subtypes for their possible impact on OS. Results: The 5-year OS was 63.2%. Significant association was found between OS and age (log-rank 12.455, p=0.006), tumor size (log-rank 26.425, p=0.000), grade (log-rank 13.249, p=0.000) and stage (log-rank 43.235, p=0.000). Univariate analysis indicated size (p=0.000), grade (p=0.001) and stage (p=0.000) as prognostic factors for OS. In multivariate analysis, grade (p=0.014) and stage (p=0.000) remained significant predictors of OS. Conclusion: Tumor grade and stage were identified as independent prognostic factors of OS survival in Serbian patients with RCC. © 2017 Zerbinis Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clinicopathological characteristics and survival in Serbian patients with renal cell carcinoma: A retrospective analysis
    (2017)
    Pavlovic, Ivan (56769363700)
    ;
    Pejic, Snezana (6602841944)
    ;
    Glumac, Sofija (33467624700)
    ;
    Todorovic, Ana (8930796800)
    ;
    Stojiljkovic, Vesna (8930796500)
    ;
    Popovic, Natasa (15832791100)
    ;
    Gavrilovic, Ljubica (23060209300)
    ;
    Pajovic, Snezana B. (6701715237)
    ;
    Radojevic-Skodric, Sanja (15726145200)
    ;
    Dzamic, Zoran (6506981365)
    ;
    Basta-Jovanovic, Gordana (6603093303)
    Purpose: Indications of kidney cancer outcome in lower-income countries are based on an incidence/mortality ratio due to lack of survival information. This study was conducted to provide outcome data in Serbian patients with renal cell carcinoma (RCC) and to identify prognostic factors that could affect their overall survival (OS). Methods: This retrospective study included 185 patients who underwent nephrectomy. We assessed certain clinicopathological data including age, gender, tumor size, grade, stage and histological subtypes for their possible impact on OS. Results: The 5-year OS was 63.2%. Significant association was found between OS and age (log-rank 12.455, p=0.006), tumor size (log-rank 26.425, p=0.000), grade (log-rank 13.249, p=0.000) and stage (log-rank 43.235, p=0.000). Univariate analysis indicated size (p=0.000), grade (p=0.001) and stage (p=0.000) as prognostic factors for OS. In multivariate analysis, grade (p=0.014) and stage (p=0.000) remained significant predictors of OS. Conclusion: Tumor grade and stage were identified as independent prognostic factors of OS survival in Serbian patients with RCC. © 2017 Zerbinis Publications. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback